CYP27A1 and breast carcinoma: Kimbung et al. observed that higher tumor expression of CYP27A1 mRNA in ER-positive breast cancer patients was associated with longer overall survival and recurrence-free survival in ER+ breast cancer patients under the age of 50 [72].